DI
LRMR icon

Disciplined Investments’s Larimar Therapeutics LRMR Stock Holding History

Disciplined Investments’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-116
Closed -$363 – 926
2023
Q2 		$363 Hold
116
– – ﹤0.01% 1340
2023
Q1 		$526 Hold
116
– – ﹤0.01% 1209
2022
Q4 		$480 Hold
116
– – ﹤0.01% 1198
2022
Q3 		$0 Hold
116
– – ﹤0.01% 1436
2022
Q2 		$0 Hold
116
– – ﹤0.01% 1470
2022
Q1 		$0 Hold
116
– – ﹤0.01% 1499
2021
Q4 		$1K Hold
116
– – ﹤0.01% 474
2021
Q3 		$1K Hold
116
– – ﹤0.01% 425
2021
Q2 		$1K Buy
+116
New +$1.31K ﹤0.01% 408

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return